Review article · 2024 · Open access
KDOQI US Commentary on the KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of CKD
American Journal of Kidney Diseases, 85(2), 135–176 · Published 18 November 2024 · DOI 10.1053/j.ajkd.2024.08.003
In brief
“KDOQI US Commentary on the KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of CKD” is a 2024 review article by Sankar Dass Navaneethan and 12 co-authors, published in American Journal of Kidney Diseases. OpenAlex counts 121 citations as of 15 November 2026. It is open access: the full text is free to read at American Journal of Kidney Diseases.
- Citations
- 121
- Most cited in
- 2026 (71)
- Field-weighted impact
- 5.45
- References
- 221
- Authors
- 13
Cite this paper
Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.
APA 7
Navaneethan, S. D., Bansal, N., Cavanaugh, K. L., Chang, A. R., Crowley, S. T., Delgado, C., Estrella, M. M., Ghossein, C., Ikizler, T. A., Koncicki, H. M., Peter, W. L. S., Tuttle, K. R., & William, J. H. (2024). KDOQI US Commentary on the KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of CKD. American Journal of Kidney Diseases, 85(2), 135–176. https://doi.org/10.1053/j.ajkd.2024.08.003
MLA 9
Navaneethan, Sankar Dass, et al. “KDOQI US Commentary on the KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of CKD.” American Journal of Kidney Diseases, vol. 85, no. 2, 2024, pp. 135–176. https://doi.org/10.1053/j.ajkd.2024.08.003.
Chicago
Navaneethan, Sankar Dass, Nisha Bansal, Kerri L. Cavanaugh, Alex R. Chang, Susan T. Crowley, Cynthia Delgado, Michelle M. Estrella, et al. 2024. “KDOQI US Commentary on the KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of CKD.” American Journal of Kidney Diseases 85 (2): 135–176. https://doi.org/10.1053/j.ajkd.2024.08.003.
Harvard
Navaneethan, S. D. et al. (2024) ‘KDOQI US Commentary on the KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of CKD’, American Journal of Kidney Diseases, 85(2), pp. 135–176. doi:10.1053/j.ajkd.2024.08.003.
IEEE
S. D. Navaneethan et al., “KDOQI US Commentary on the KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of CKD,” American Journal of Kidney Diseases, vol. 85, no. 2, pp. 135–176, 2024, doi: 10.1053/j.ajkd.2024.08.003.
BibTeX
@article{navaneethan2024kdoqi,
title = {{KDOQI US Commentary on the KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of CKD}},
author = {Navaneethan, Sankar Dass and Bansal, Nisha and Cavanaugh, Kerri L. and Chang, Alex R. and Crowley, Susan T. and Delgado, Cynthia and Estrella, Michelle M. and Ghossein, Cybele and Ikizler, Talat Alp and Koncicki, Holly M. and Peter, Wendy L. St. and Tuttle, Katherine R. and William, Jeffrey H.},
journal = {American Journal of Kidney Diseases},
year = {2024},
volume = {85},
number = {2},
pages = {135--176},
doi = {10.1053/j.ajkd.2024.08.003},
url = {https://doi.org/10.1053/j.ajkd.2024.08.003}
}
Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)
Citations by year
| Year | Citations | Share of the best year |
|---|---|---|
| 2017 | 1 | |
| 2019 | 1 | |
| 2020 | 3 | |
| 2021 | 2 | |
| 2022 | 3 | |
| 2023 | 4 | |
| 2025 | 36 | |
| 2026 | 71 |
Its field-weighted citation impact is 5.45: it has been cited 5.45 times as often as the average work of the same field, type and year (1.00 is the world average).
Topic and keywords
Health Sciences › Medicine › Nephrology › Chronic Kidney Disease and Diabetes
- chronic kidney disease
- chronic kidney disease progression
- cardiovascular outcomes
- SGLT2 inhibitors
- GLP-1 receptor agonists
- non-steroidal mineralocorticoid receptor antagonists
- type 2 diabetes
- team-based care
Work with this paper
Most-cited papers in Medicine
- Yaşlı Kadınlarda Üreme SağlığıDemet Kokanalı, Yaprak Engin Üstün · Jinekoloji-Obstetrik ve Neonatoloji Tıp Dergisi · 2019 · 169,630 citations
- Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 CountriesHyuna Sung, Adalberto M. Filho, Mathieu Laversanne and 5 more · CA A Cancer Journal for Clinicians · 2021 · 119,885 citations
- “Mini-mental state”Marshal F. Folstein, Susan E. Folstein, Paul R. McHugh · Journal of Psychiatric Research · 1975 · 90,424 citations
- Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countriesFreddie Bray, Jacques Ferlay, Isabelle Soerjomataram and 3 more · CA A Cancer Journal for Clinicians · 2018 · 87,396 citations
- Hallmarks of Cancer: The Next GenerationDouglas Hanahan, Robert A. Weinberg · Cell · 2011 · 69,758 citations
Questions about this paper
How do I cite this paper in APA style?
Navaneethan, S. D., Bansal, N., Cavanaugh, K. L., Chang, A. R., Crowley, S. T., Delgado, C., Estrella, M. M., Ghossein, C., Ikizler, T. A., Koncicki, H. M., Peter, W. L. S., Tuttle, K. R., & William, J. H. (2024). KDOQI US Commentary on the KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of CKD. American Journal of Kidney Diseases, 85(2), 135–176. https://doi.org/10.1053/j.ajkd.2024.08.003
How many times has this paper been cited?
121 times, according to OpenAlex on 15 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.
Is this paper free to read?
Yes. It is open access: read the free full text at American Journal of Kidney Diseases.
Who wrote this paper?
Sankar Dass Navaneethan, Nisha Bansal, Kerri L. Cavanaugh, Alex R. Chang, Susan T. Crowley, Cynthia Delgado, Michelle M. Estrella, Cybele Ghossein, Talat Alp Ikizler, Holly M. Koncicki, Wendy L. St. Peter, Katherine R. Tuttle and 1 more.
What is the DOI of this paper?
10.1053/j.ajkd.2024.08.003. The permanent link is https://doi.org/10.1053/j.ajkd.2024.08.003.
Bibliographic data from OpenAlex (CC0), last checked 15 November 2026. ResearchGuru does not host this paper; the links go to the publisher or the repository that does.